Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Federal Trade Commission
Deloitte
Fuji
Argus Health
Express Scripts
Accenture
Mallinckrodt
Fish and Richardson
Farmers Insurance

Generated: May 26, 2018

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 077174

« Back to Dashboard

NDA 077174 describes FOSCARNET SODIUM, which is a drug marketed by Hospira and is included in one NDA. Additional details are available on the FOSCARNET SODIUM profile page.

The generic ingredient in FOSCARNET SODIUM is foscarnet sodium. There are seven drug master file entries for this compound. One supplier is listed for this compound. Additional details are available on the foscarnet sodium profile page.
Summary for 077174
Tradename:FOSCARNET SODIUM
Applicant:Hospira
Ingredient:foscarnet sodium
Patents:0
Therapeutic Class:Antivirals
Formulation / Manufacturing:see details
Medical Subject Heading (MeSH) Categories for 077174

Profile for product number 001

Active Rx/OTC/Discontinued:DISCNDosage:INJECTABLE;INJECTIONStrength2.4GM/100ML
Approval Date:May 31, 2005TE:RLD:No

Complete Access Available with Subscription

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Chubb
Cantor Fitzgerald
Deloitte
Covington
McKinsey
QuintilesIMS
Colorcon
Cerilliant
Farmers Insurance

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.